First Detection of Antibodies Specific to Crimean-Congo Hemorrhagic Fever Virus in Rural Populations of Gabon

Am J Trop Med Hyg. 2024 Jul 23;111(4):880-886. doi: 10.4269/ajtmh.24-0054. Print 2024 Oct 2.

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral disease with a mortality rate reaching up to 40% in humans. Currently, CCHF affects three continents: Asia, Europe, and Africa. An increase in confirmed cases in Africa has been observed since 2000. In Central Africa, several countries have reported the circulation of CCHV virus (CCHFV). However, in Gabon, there is a lack of recent data on the circulation of the virus in the Gabonese population. To provide an overview of the epidemiological situation in Gabon, we tested 3,081 human serum samples collected between 2005 and 2008 in villages throughout the country for anti-CCHFV antibodies. Using a double-antigen ELISA kit, our study found 15/3,081 samples positive for CCHFV. These positive samples were also tested using the Blackbox CCHFV IgG kit and the Luminex technique. These analyses confirmed seven and four positives for the Blackbox CCHFV IgG kit and the Luminex technique, respectively. This study suggests low circulation of CCHFV in the rural human population of Gabon. Competent authorities must survey CCHFV to identify and prevent clinical cases in the human population.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral* / blood
  • Child
  • Child, Preschool
  • Enzyme-Linked Immunosorbent Assay*
  • Female
  • Gabon / epidemiology
  • Hemorrhagic Fever Virus, Crimean-Congo* / immunology
  • Hemorrhagic Fever, Crimean* / epidemiology
  • Hemorrhagic Fever, Crimean* / immunology
  • Hemorrhagic Fever, Crimean* / virology
  • Humans
  • Immunoglobulin G / blood
  • Male
  • Middle Aged
  • Rural Population*
  • Young Adult

Substances

  • Antibodies, Viral
  • Immunoglobulin G